Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
One of the oldest and most preserved of the homeostatic responses of the body to injury is the acute phase protein response associated with inflammation. The liver responds to hormone-like mediators by the increased synthesis of a series of plasma proteins called acute phase reactants. In these studies, we examined the relationship of hepatocyte-stimulating factor derived from peripheral blood monocytes to interferon beta 2 (IFN-beta 2), which has been cloned. Antibodies raised against fibroblast-derived IFN-beta having neutralizing activity against both IFN-beta 1 and -beta 2 inhibited the major hepatocyte-stimulating activity derived from monocytes. Fibroblast-derived mediator elicited the identical stimulated response in human HepG2 cells and primary rat hepatocytes as the monocyte cytokine. Finally, recombinant-derived human B-cell stimulatory factor type 2 (IFN-beta 2) from Escherichia coli induced the synthesis of all major acute phase proteins studied in human hepatoma HepG2 and primary rat hepatocyte cultures. These data demonstrate that monocyte-derived hepatocyte-stimulating factor and IFN-beta 2 share immunological and functional identity and that IFN-beta 2, also known as B-cell stimulatory factor and hybridoma plasmacytoma growth factor, has the hepatocyte as a major physiologic target and thereby is essential in controlling the hepatic acute phase response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Dinarello, C. A. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.1.51 · Cited by 1,644
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22124.x · Cited by 1,479
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
Le, J., & Vilček, J. (1987) · PubMed · Cited by 1,327
Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., & Van Snick, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.914 · Cited by 669
Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.
Perlmutter, D. H., Dinarello, C. A., Punsal, P. I., & Colten, H. R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112721 · Cited by 574
Kohase, M., Henriksen-DeStefano, D., May, L. T., Vilček, J., & Sehgal, P. B. (1986) · Cell · doi:10.1016/0092-8674(86)90780-4 · Cited by 567
Zilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 487
Corticotropin-Releasing Activity of Monokines
Woloski, B. M. R. N. J., Smith, E. M., Meyer, W. J., Fuller, G. M., & Blalock, J. E. (1985) · Science · doi:10.1126/science.2997929 · Cited by 486
Cited by
Items 101–197 of 197
Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
Stevens, C., Walz, G., Singaram, C., Lipman, M. L., Zanker, B., Muggia, A., Antonioli, D., Peppercorn, M. A., & Strom, T. B. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01300378 · Cited by 331
Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Fassbender, K., Rossol, S., Kammer, T., Daffertshofer, M., Wirth, S., Dollman, M., & Hennerici, M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90289-5 · Cited by 325
Duncan, M. R., & Berman, B. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483971 · Cited by 323
INTERLEUKIN-6 STIMULATES ANTERIOR PITUITARY HORMONE RELEASE IN VITRO.
SPANGELO, B. L., JUDD, A. M., ISAKSON, P. C., & MACLEOD, R. M. (1989) · Endocrinology · doi:10.1210/endo-125-1-575 · Cited by 320
Van Damme, J., Van Beeumen, J., Opdenakker, G., & Billiau, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1364 · Cited by 314
Gomez, R., Romero, R., Edwin, S. S., & David, C. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70347-0 · Cited by 312
Humanised monoclonal antibody therapy for rheumatoid arthritis
Isaacs, J. D., Hale, G., Cobbold, S. P., Waldmann, H., Watts, R. A., Hazleman, B. L., & Keogan, M. T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92294-p · Cited by 308
IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
Manore, S. G., Doheny, D. L., Wong, G. L., & Lo, H.-W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.866014 · Cited by 307
Matsuda, T., And, T. H., & Kishimoto, T. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180618 · Cited by 304
Hypoxic Stress Induces Cardiac Myocyte–Derived Interleukin-6
Yamauchi-Takihara, K., Ihara, Y., Ogata, A., Yoshizaki, K., Azuma, J., & Kishimoto, T. (1995) · Circulation · doi:10.1161/01.cir.91.5.1520 · Cited by 304
Visvanathan, K. V., & Goodbourn, S. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03483.x · Cited by 303
Nutritional Aspects of Leukocytic Cytokines
Klasing, K. C. (1988) · The Journal of Nutrition · doi:10.1093/jn/118.12.1436 · Cited by 303
Sallenave, J. M., Shulmann, J., Crossley, J., Jordana, M., & Gauldie, J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.6.7946401 · Cited by 301
Self-citationEndotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo
Shalaby, M. R., Waage, A., Aarden, L., & Espevik, T. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90010-x · Cited by 294
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Tanabe, O., Akira, S., Kamiya, T., Wong, G. G., Hirano, T., & Kishimoto, T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.11.3875 · Cited by 293
Schultz, D. R., & Arnold, P. I. (1990) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(90)90055-k · Cited by 293
Stunting Is Characterized by Chronic Inflammation in Zimbabwean Infants
Prendergast, A. J., Rukobo, S., Chasekwa, B., Mutasa, K., Ntozini, R., Mbuya, M. N. N., Jones, A., Moulton, L. H., Stoltzfus, R. J., & Humphrey, J. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086928 · Cited by 290
CASTELL, J. V., GEIGER, T., GROSS, V., ANDUS, T., WALTER, E., HIRANO, T., KISHIMOTO, T., & HEINRICH, P. C. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14383.x · Cited by 290
Impaired neuroglial activation in interleukin-6 deficient mice
Klein, M. A., M�ller, J. C., Jones, L. L., Bluethmann, H., Kreutzberg, G. W., & Raivich, G. (1997) · Glia · doi:10.1002/(sici)1098-1136(199703)19:3<227::aid-glia5>3.0.co;2-w · Cited by 289
How much is too much? Interleukin-6 and its signalling in atherosclerosis
Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., & Schieffer, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0297 · Cited by 289
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., & Scheller, J. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.007 · Cited by 289
Elevation of circulating interleukin 6 after surgery: Factors influencing the serum level
Sakamoto, K., Arakawa, H., Mita, S., Ishiko, T., Ikei, S., Egami, H., Hisano, S., & Ogawa, M. (1994) · Cytokine · doi:10.1016/1043-4666(94)90040-x · Cited by 286
Zhang, Y. H., Lin, J. X., Yip, Y. K., & Vilcek, J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6802 · Cited by 286
Isshiki, H., Akira, S., Tanabe, O., Nakajima, T., Shimamoto, T., Hirano, T., & Kishimoto, T. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2757 · Cited by 285
Ramadori, G., Van Damme, J., Rieder, H., & Zum Büschenfelde, K. M. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180817 · Cited by 284
Lotz, M., & Guerne, P. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52202-x · Cited by 283
cDNA cloning of murine interleukin-HP1: homology with human interleukin 6
Snick, J. V., Cayphas, S., Szikora, J.-P., Renauld, J.-C., Roost, E. V., Boon, T., & Sirnpson, R. J. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180202 · Cited by 282
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
McElvaney, O. J., Curley, G. F., Rose-John, S., & McElvaney, N. G. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00103-x · Cited by 278
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Ray, A., LaForge, K. S., & Sehgal, P. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5736 · Cited by 274
Induction of interleukin-6 in axotomized sensory neurons
Murphy, P., Grondin, J., Altares, M., & Richardson, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05130.1995 · Cited by 273
Hirohata, S., & Miyamoto, T. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330506 · Cited by 273
Monocyte-Derived Human B-Cell Growth Factor Identified as Interferon-β 2 (BSF-2, IL-6)
Tosato, G., Seamon, K. B., Goldman, N. D., Sehgal, P. B., May, L. T., Washington, G. C., Jones, K. D., & Pike, S. E. (1988) · Science · doi:10.1126/science.2829354 · Cited by 272
Perspectives: Interleukin-6: An osteotropic factor?
Roodman, G. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070502 · Cited by 272
Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family.
Chang, C. J., Chen, T. T., Lei, H. Y., Chen, D. S., & Lee, S. C. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6642 · Cited by 269
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
Dayer, J.-M., & Choy, E. (2010) · Rheumatology · doi:10.1093/rheumatology/kep329 · Cited by 267
Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma
Zhang, X., Klein, B., & Bataille, R. (1989) · Blood · doi:10.1182/blood.v74.1.11.11 · Cited by 266
Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6.
Ganter, U., Arcone, R., Toniatti, C., Morrone, G., & Ciliberto, G. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08554.x · Cited by 265
Interleukin-6 and Cardiovascular Diseases
Kanda, T., & Takahashi, T. (2004) · Japanese Heart Journal · doi:10.1536/jhj.45.183 · Cited by 265
Ohno, M., & Abe, T. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90327-c · Cited by 265
Zhang, Y., Lin, J.-X., & Vilček, J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3818-3823.1990 · Cited by 263
Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions
Seino, Y., Ikeda, U., Ikeda, M., Yamamoto, K., Misawa, Y., Hasegawa, T., Kano, S., & Shimada, K. (1994) · Cytokine · doi:10.1016/1043-4666(94)90013-2 · Cited by 263
Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis
Harada, T., Yoshioka, H., Yoshida, S., Iwabe, T., Onohara, Y., Tanikawa, M., & Terakawa, N. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70553-2 · Cited by 262
Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes
Alles, V., Bottazzi, B., Peri, G., Golay, J., Introna, M., & Mantovani, A. (1994) · Blood · doi:10.1182/blood.v84.10.3483.3483 · Cited by 261
Blay, J.-Y., Rossi, J.-F., Wijdenes, J., Menetrier-Caux, C., Schemann, S., Négrier, S., Philip, T., & Favrot, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970729)72:3<424::aid-ijc9>3.0.co;2-r · Cited by 261
Zhang, Y., Lin, J. X., & Vilcek, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68768-x · Cited by 254
Lippitz, B. E., & Harris, R. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1093722 · Cited by 248
Sensitive ELISA for interleukin-6
Helle, M., Boeije, L., de Groot, E., de Vos, A., & Aarden, L. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90063-l · Cited by 248
SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130
Lehmann, U., Schmitz, J., Weissenbach, M., Sobota, R. M., Hörtner, M., Friederichs, K., Behrmann, I., Tsiaris, W., Sasaki, A., Schneider-Mergener, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210552200 · Cited by 236
IL-6 cytokine family and signal transduction: a model of the cytokine system
Hibi, M., Nakajima, K., & Hirano, T. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00202068 · Cited by 233
“IL-6, LIE IL-11, and OSM stimulate the biosynthesis of acute-phase proteins in hepatocytes [36, 37, 78-81].”
BackgroundGlucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts
Waage, A., Slupphaug, G., & Shalaby, R. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201112 · Cited by 231
Clinical and nutritional aspects of changes in acute-phase proteins during inflammation
Fleck, A. (1989) · Proceedings of the Nutrition Society · doi:10.1079/pns19890050 · Cited by 231
Antitumor activity of recombinant interleukin 6 in mice.
Mulé, J. J., McIntosh, J. K., Jablons, D. M., & Rosenberg, S. A. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.3.629 · Cited by 227
Modifiable risk factors in periodontitis: at the intersection of aging and disease
Reynolds, M. A. (2014) · Periodontology 2000 · doi:10.1111/prd.12047 · Cited by 226
Endotoxin-induced cytokine gene expression and excretion in the liver
Luster, M. I., Germolec, D. R., Yoshida, T., Kayama, F., & Thompson, M. (1994) · Hepatology · doi:10.1002/hep.1840190229 · Cited by 224
Interleukin-6 gene expression in Castleman's disease
Leger-Ravet, M., Peuchmaur, M., Devergne, O., Audouin, J., Raphael, M., Van Damme, J., Galanaud, P., Diebold, J., & Emilie, D. (1991) · Blood · doi:10.1182/blood.v78.11.2923.2923 · Cited by 223
Febrile Core Temperature Is Essential for Optimal Host Defense in Bacterial Peritonitis
Jiang, Q., Cross, A. S., Singh, I. S., Chen, T. T., Viscardi, R. M., & Hasday, J. D. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1265-1270.2000 · Cited by 217
“It limits the early inflammatory response by inhibiting expression of TNF-a and IL-1, but IL-6 also induces expression of acutephase reactants and generation of T- and B-cell-dependent immune responses (13, 16).”
BackgroundPhase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
Weber, J., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H., & Cole, D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.499 · Cited by 216
Interleukin-6 and its relation to inflammation and disease
Hirano, T. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90042-m · Cited by 208
Interleukin 6 Is Important for Survival After Partial Hepatectomy in Mice
Blindenbacher, A., Wang, X., Langer, I., Savino, R., Terracciano, L., & Heim, M. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50378 · Cited by 202
Arruda, J. L., Sweitzer, S., Rutkowski, M. D., & DeLeo, J. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02807-9 · Cited by 200
Horiuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Interleukin 6 is an autocrine growth factor for mesangial cells
Ruef, C., Budde, K., Lacy, J., Northemann, W., Baumann, M., Sterzel, R. B., & Coleman, D. L. (1990) · Kidney International · doi:10.1038/ki.1990.193 · Cited by 194
Interleukin-1 induces interleukin-6 production in peripheral blood monocytes
Tosato, G., & Jones, K. (1990) · Blood · doi:10.1182/blood.v75.6.1305.1305 · Cited by 193
ANDUS, T., GEIGER, T., HIRANO, T., KISHIMOTO, T., TRAN‐THI, T., DECKER, K., & HEINRICH, P. C. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13997.x · Cited by 188
Guerne, P., Terkeltaub, R., Zuraw, B., & Lotz, M. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780321114 · Cited by 188
The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat
van Gool, J., van Vugt, H., Helle, M., & Aarden, L. A. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90034-n · Cited by 179
Interleukin-6 is the Major Regulator of Acute Phase Protein Synthesis in Rat and Man
CASTELL, J. V., DAVID, M., KLAPPROTH, J., HEINRICH, P. C., ANDUS, T., GEIGER, T., GÓMEZ-LECHÓN, M., HIRANO, T., & KISHIMOTO, T. (1989) · Advances in Immunopharmacology · doi:10.1016/b978-0-08-036149-9.50026-9 · Cited by 177
Oster, W., Cicco, N. A., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., Mertelsmann, R. H., & Herrmann, F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114186 · Cited by 175
RetractedInterleukin 6 in autoimmune and inflammatory diseases: a personal memoir
HIRANO, T. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.717 · Cited by 172
The soluble interleukin 6 receptor: advanced therapeutic options in inflammation
Rose‐John, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.782 · Cited by 169
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study
Podolanczuk, A. J., Oelsner, E. C., Barr, R. G., Hoffman, E. A., Armstrong, H. F., Austin, J. H. M., Basner, R. C., Bartels, M. N., Christie, J. D., Enright, P. L., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00129-2016 · Cited by 167
The mechanisms and treatment of weight loss in cancer
Fearon, K. C. H. (1992) · Proceedings of the Nutrition Society · doi:10.1079/pns19920036 · Cited by 164
Dittrich, E., Haft, C. R., Muys, L., Heinrich, P. C., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5487 · Cited by 160
“…the regulation of myeloma/plasmacytoma (Kawano et al., 1988; Schwab et al., 1991) and hybridoma proliferation (Nordan and Potter, 1986; Van Damme et al., 1987), and the induction of acute phase protein synthesis in liver cells (Gauldie et al., 1987; Andus et al., 1987, 1988; Castell et al., 1990).”
BackgroundMiyaura, C., Onozaki, K., Akiyama, Y., Taniyama, T., Hirano, T., Kishimoto, T., & Suda, T. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81293-6 · Cited by 159
Change in C-reactive protein levels and FEV1 decline: A longitudinal population-based study
Shaaban, R., Kony, S., Driss, F., Leynaert, B., Soussan, D., Pin, I., Neukirch, F., & Zureik, M. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.03.027 · Cited by 158
Role of Interleukin-6 in Vascular Health and Disease
Villar-Fincheira, P., Sanhueza-Olivares, F., Norambuena-Soto, I., Cancino-Arenas, N., Hernandez-Vargas, F., Troncoso, R., Gabrielli, L., & Chiong, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.641734 · Cited by 154
Synergistic activation of human t cells by interleukin 1 and interleukin 6
Houssiau, F. A., Coulie, P. G., Olive, D., & Snick, J. V. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180427 · Cited by 152
Real time analysis of STAT3 nucleocytoplasmic shuttling
Pranada, A. L., Metz, S., Herrmann, A., Heinrich, P. C., & Müller-Newen, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312530200 · Cited by 140
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
Nieken, J., Mulder, N., Buter, J., Vellenga, E., Limburg, P., Piers, D., & de Vries, E. (1995) · Blood · doi:10.1182/blood.v86.3.900.900 · Cited by 128
Kim, H., Hawley, T. S., Hawley, R. G., & Baumann, H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1525 · Cited by 119
Self-citationSongür, N., Kuru, B., Kalkan, F., Özdilekcan, Ç., Çakmak, H., & Hızel, N. (2004) · Tumori Journal · doi:10.1177/030089160409000207 · Cited by 96
Walter, P. B., Macklin, E. A., Porter, J., Evans, P., Kwiatkowski, J. L., Neufeld, E. J., Coates, T., Giardina, P. J., Vichinsky, E., Olivieri, N., et al. (2008) · Haematologica · doi:10.3324/haematol.11755 · Cited by 87
Kanatani, M., Sugimoto, T., Sowa, H., Kobayashi, T., Kanzawa, M., & Chihara, K. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20041 · Cited by 74
“IL-6 is produced in a variety of tissues, such as bone (Girasole et al., 1992), the thyroid (Weetmann et al., 1990), and blood mononuclear cells (Gauldie et al., 1987).”
BackgroundFISCHER, P., LEHMANN, U., SOBOTA, R. M., SCHMITZ, J., NIEMAND, C., LINNEMANN, S., HAAN, S., BEHRMANN, I., YOSHIMURA, A., JOHNSTON, J. A., et al. (2004) · Biochemical Journal · doi:10.1042/bj20030893 · Cited by 72
Hermanns, H. M., Radtke, S., Haan, C., Schmitz-Van de Leur, H., Tavernier, J., Heinrich, P. C., & Behrmann, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6651 · Cited by 71
Miyazawa, K., Mori, A., Yamamoto, K., & Okudaira, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7620 · Cited by 69
Herbert, R. P., Harris, J., Chong, K. P., Chapman, J., West, A. K., & Chuah, M. I. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-109 · Cited by 69
Emptoz-Bonneton, A., Crave, J. C., Lejeune, H., Brébant, C., & Pugeat, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4362 · Cited by 68
“sion of acute phase proteins by HepG2 cells have previously been reported ( 25 ).”
BackgroundVisseren, F. L. J., Verkerk, M. S. A., Van Der Bruggen, T., Marx, J. J. M., Van Asbeck, B. S., & Diepersloot, R. J. A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1084.x · Cited by 64
Hirano, T., & Kishimoto, T. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_14 · Cited by 57
Endotoxin Stimulates Hepatocyte Interleukin-6 Production
Panesar, N., Tolman, K., & Mazuski, J. E. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5648 · Cited by 56
Remmler, J., Schneider, C., Treuner-Kaueroff, T., Bartels, M., Seehofer, D., Scholz, M., Berg, T., & Kaiser, T. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.017 · Cited by 56
Role of macrophages in regeneration of liver
Shiratori, Y., Hongo, S., Hikiba, Y., Ohmura, K., Nagura, T., Okano, K., Kamii, K., Tanaka, T., Komatsu, Y., Ochiai, T., et al. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093593 · Cited by 38
Metadata
- Authors
- Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-10
- Volume
- 84
- Issue
- 20
- Pages
- 7251-7255
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2036452124
- Cited by
- 1,635
- References
- 34
- FWCI
- 67.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.